
402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes
Author(s) -
Bahareh Rajaei,
Annina L. Roelofsen,
Ehsan Shokrollahi,
Bas Brinkhof,
Eleumovska,
Ronald J. van der Sluis,
Maaike Nieveen,
Marten A. Engelse,
Eelco de Koning,
Françoise Carlotti
Publication year - 2021
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000804432.75585.bf
Subject(s) - pdx1 , induced pluripotent stem cell , transplantation , cell therapy , progenitor cell , stem cell , cellular differentiation , biology , microbiology and biotechnology , beta cell , directed differentiation , cancer research , immunology , insulin , medicine , embryonic stem cell , endocrinology , islet , biochemistry , gene